Integrating Virtual Reality, Neurofeedback, and Cognitive Behavioral Therapy for Auditory Verbal Hallucinations (Hybrid): Protocol of a Pilot, Unblinded, Single-Arm Interventional Study
JMIR Research Protocols · 2025
DOI: 10.2196/63405 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Jessica Spark und 16 weiteren Autor:innen. Beteiligte Einrichtung: Orygen, Parkville, Australia. Hauptthemen laut MEDLINE: Hallucinations, Cognitive Behavioral Therapy, Neurofeedback, Virtual Reality. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHMRC Investigator Grant.
Abstract (Originalsprache)
Background
Current treatments for schizophrenia and other psychotic disorders have limited efficacy, with high rates of nonresponse to “gold standard” treatments. New approaches are therefore urgently required.
Objective
The aims of this pilot study are to investigate the feasibility, acceptability, safety, and usability of Hybrid treatment (primary aim); and to explore Hybrid’s treatment efficacy and engagement of treatment targets (secondary aim). The primary aim will be assessed via face-to-face user experience surveys on a (self-assessed) 5-point Likert scale (and qualitative open-ended questions) examining: (1) acceptability, (2) helpfulness, (3) engagement, and (4) perceived safety. We will also examine consent and completion rates, and the number of sessions attended. Our threshold for moving on to efficacy trials will be at least 70% of our participants to rate 3 and above (which corresponds to agree or strongly agree) that the intervention package was acceptable, feasible, and safe. The secondary aims will be assessed by observing whether individuals achieve self-directed modulation of high-β neurophysiological activity (neural target) and progression upwards through the VR-based exposure hierarchy (psychological target), and by assessing symptom change scores. This study developed a new treatment approach for auditory verbal hallucinations, a major symptom of psychotic disorders, that integrates advances in psychological therapy (cognitive behavioral therapy for psychosis), technology (virtual reality, VR), and neuroscience (electroencephalography-based neurofeedback).
Methods
Hybrid takes a “symptom capture” approach using individually tailored VR-based exposure exercises.
Participants
(N=10) will receive the intervention package weekly over 12 face-to-face sessions. Here, participants will be progressively exposed to symptom triggers and develop methods of downregulating neural activity associated with these symptoms (neurofeedback component) while concurrently receiving clinician-delivered cognitive behavioral therapy for psychosis.
Results
As of February 2025, Hybrid has commenced (unblinded) recruitment activities from Orygen clinical services in Northwestern Melbourne, Australia. A total of 75 individuals have been approached and 64 individuals have been prescreened (41 individuals were deemed eligible, 15 individuals were ineligible, and 8 individuals declined or did not respond to contact attempts) and 5 individuals have been included in the study. Of the 5 individuals who have commenced the Hybrid treatment, 4 are actively engaged in the program and 1 individual has withdrawn. We expect recruitment to conclude in July 2025 and for the results to be published in 2026.
Conclusions
The Hybrid study is piloting a novel approach that has the potential to address the shortcomings of current treatments for psychotic symptoms. If there is favorable evidence for the acceptability, feasibility, safety and usability of Hybrid, the study team will move on to efficacy trials. Trial Registration Australian New Zealand Clinical Trials Registry ACTRN12624000357550; https://tinyurl.com/24ey8hpy International Registered Report Identifier (IRRID) PRR1-10.2196/63405
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Orygen, Parkville, Australia.
- Centre for Youth Mental Health, University of Melbourne, Parkville, Australia.
- School of Psychology, Deakin University, Burwood, Australia.
- The Cairnmillar Institute, Hawthorn East, Australia.
- Centre for Mental Health and Brain Sciences, Swinburne University of Technology, Hawthorn, Australia.
- School of Computing and Information Systems, University of Melbourne, Parkville, Australia.
ORCID-Profile: Jessica Spark, Elise Rowe, Mario Alvarez-Jimenez, Imogen Bell, Linda Byrne, Ilvana Dzafic, Carli Ellinghaus, Suzie Lavoie, Jarrad Lum, Brooke McLean, Neil Thomas, Andrew Thompson, Greg Wadley, Thomas Whitford, Stephen Wood, Hok Pan Yuen, Barnaby Nelson
Förderung
- NHMRC Investigator Grant
Zitieren
APA
Spark, J., Rowe, E., Alvarez-Jimenez, M., Bell, I., Byrne, L., Dzafic, I., Ellinghaus, C., Lavoie, S., Lum, J., McLean, B., Thomas, N., Thompson, A., Wadley, G., Whitford, T., Wood, S., Yuen, H. P., & Nelson, B. (2025). Integrating Virtual Reality, Neurofeedback, and Cognitive Behavioral Therapy for Auditory Verbal Hallucinations (Hybrid): Protocol of a Pilot, Unblinded, Single-Arm Interventional Study. JMIR Research Protocols. https://doi.org/10.2196/63405
Vancouver
Spark J, Rowe E, Alvarez-Jimenez M, Bell I, Byrne L, Dzafic I, et al. Integrating Virtual Reality, Neurofeedback, and Cognitive Behavioral Therapy for Auditory Verbal Hallucinations (Hybrid): Protocol of a Pilot, Unblinded, Single-Arm Interventional Study. JMIR Research Protocols. 2025. doi:10.2196/63405
BibTeX
@article{Spark2025,
author = {Spark, Jessica and Rowe, Elise and Alvarez-Jimenez, Mario and Bell, Imogen and Byrne, Linda and Dzafic, Ilvana and Ellinghaus, Carli and Lavoie, Suzie and Lum, Jarrad and McLean, Brooke and Thomas, Neil and Thompson, Andrew and Wadley, Greg and Whitford, Thomas and Wood, Stephen and Yuen, Hok Pan and Nelson, Barnaby},
title = {Integrating Virtual Reality, Neurofeedback, and Cognitive Behavioral Therapy for Auditory Verbal Hallucinations (Hybrid): Protocol of a Pilot, Unblinded, Single-Arm Interventional Study},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/63405}
}
EUVIMED